Renal and circulatory effects of large volume plasma expansion in patients with hepatorenal syndrome type 1
Journal Title: Annals of Hepatology - Year 2012, Vol 11, Issue 2
Abstract
Introduction. Hepatorenal syndrome type I (HRS I) may be a consequence of circulatory dysfunction in cirrhotic patients with portal hypertension. This uncontrolled interventional pilot study examines the hemodynamic and renal effects of large volume plasma expansion in HRS I. Material and methods. 14 cirrhotic patients (8 m, 6 f, age 60 (58-65) years) with HRS I received large volume plasma expansion with up to 400 mL of 20% human albumin solution per 12 over 48 h under hemodynamic monitoring by transpulmonary thermodilution. Creatinine clearances (ClCreat) were calculated for 12-h periods. Plasma expansion was withheld if criteria of volume overload [Extravascular lung Water Index (ELWI) > 9 mL/kg or Global End-Diastolic Volume Index (GEDI) > 820 mL/m 2 ] were met. Paracentesis was performed according to clinical necessity and treatment continued for 48 h thereafter. Serum creatinine values were observed for 12 days.Results. Patients received 1.6 (1.5-2.0) g of albumin per kg bodyweight and day for 48 to 96 h. During the treatment period, GEDVI [724 (643-751) mL/m 2 vs. 565 (488-719) mL/m 2 ; p = 0.001], cardiac index (CI) [4.9 (4.1-6.15) L/min/m 2 vs. 3.9 (3.4-5.0) L /min/m 2 ; p = 0.033], urinary output [25 (17-69) mL/h vs. 17 (8-39) mL/h; p = 0.016) and ClCreat [20 (15-47) vs. 12 (6-17); p = 0.006] increased whereas systemic vascular resistance index (SVRI), plasma renin activity (PRA) and plasma aldosterone were significantly reduced. At 48 h therewere two complete responses (serum creatinine < 133 µmol/L) and on day 12, 8 patients had a complete response. Conclusion. HRS I may respond to large volume plasma expansion with or without paracentesis.
Authors and Affiliations
Andreas Umgelter, Katrin Wagner, Wolfgang Reindl, Peter Luppa, Fabian Geisler, Roland Schmid
Keywords
Related Articles
- EP ID EP78127
- DOI -
- Views 99
- Downloads 0
Risk factors and predictors of non-alcoholic fatty liver disease in Taiwan
Background and rationale for the study. Ultrasound assessment of the severity of non-alcoholic fatty liver disease (NAFLD) shows substantial observer variability. The purpose of this retrospective study is to develop a m...
Is intestinal oxidative stress involved in patients with compensated liver cirrhosis?
Background. Liver cirrhosis is associated with intestinal epithelial barrier dysfunction, which may be affected by oxidative stress.Studies in cirrhotic rats provided evidence for intestinal oxidative stress, but studie...
Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD)
Background. There is sparse literature on the association of adipose tissue with liver histology in patients with nonalcoholic fatty liver disease (NAFLD). Aim. To study the correlation of visceral adipose...
Andres Blei (Andy) October 1949-October 2008
Treatment with Metadoxine and its impact on early mortality in patients with severe alcoholic hepatitis
Background & Aim. Despite treatment with glucocorticoids, mortality remains high in patients with severe alcoholic hepatitis. Oxidative stress and depletion of mitochondrial glutathione are implicated factors...